ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
News of Note—VBI Vaccines, BiondVax and more
fiercepharma
September 06, 2017VBI Vaccines won FDA approval for its phase 3 program of hep B shot Sci-B-Vac. Enrollment is expected to start this year in the U.S., Europe and Canada. The vaccine is already licensed in Israel and 14 other countries. Release
Pharma Sources Insight July 2025
